Chronic pain conditions are often comorbid with alcohol abuse. "Self-medication" with alcohol introduces a host of problems associated with the abuse of alcohol which over time has the potential of exacerbating the painful condition. Despite the prevalence of chronic pain being associated with alcohol abuse, rodent models which mimic the comorbid conditions are lacking. In this study, we model osteoarthritis (OA) in C57BL/6J mice by surgically destabilizing the medial meniscus (DMM). Sham-operated mice served as controls. Thirteen weeks after surgery, DMM but not sham-operated mice exhibited pronounced incapacitance of the surgically manipulated hind limb compared with the nonsurgically manipulated hind limb. At this time, the mice were exposed to the 2-bottle ethanol choice, beginning with 2.5% with a gradual increasing to 20%. Compared with sham controls, DMM mice consumed more EtOH and preferred EtOH over water at the 20% EtOH concentration. Histological analysis verified that the DMM mice exhibited significant damage to the articular cartilage and osteophyte growth compared with sham controls and these measures of the severity of OA correlated with the amount of ethanol intake. Thus, the combination of the DMM model of OA with the enhanced twobottle ethanol choice is a potential preclinical approach in mice by which the basis of the comorbid association of alcohol abuse and chronic pain conditions can be explored.
Introduction
Chronic pain and alcohol abuse are tremendous burdens to individuals and to society. Frequently, individuals resort to "selfmedication" with alcohol in an effort to relieve pain. This is readily apparent in clinical studies which have demonstrated that approximately 28% of patients with chronic pain disorders such as arthritis also abuse alcohol. 17 It is reported that younger males having arthritis are much more likely than females to selfmedicate with alcohol and that this correlates with pain continuity, frequency, depression, frustration, and marital status. 17 Although much effort has been exerted trying to investigate the underpinning causes of chronic pain and alcohol abuse separately, relatively few studies have investigated how chronic pain might instigate alcohol abuse.
Although acute alcohol has been demonstrated to provide an analgesic effect under some painful conditions, 6, 19, 20 this use of alcohol is greatly limited because of acute intoxication, addiction/ chronic abuse, and the introduction of maladaptations which can lead to cardiovascular disease, cancer, cirrhosis, and other medical problems. Chronic alcohol abuse can also lead to tolerance which can minimize its analgesic action and exacerbate allodynic and nociceptive disorders [for review see Ref. 8, 11] . Furthermore, in trauma centers, patients who abuse alcohol are more susceptible to harmful drug interactions. 1 One limiting factor that has contributed to a lack of examination of the basis of the comorbidity of chronic pain and alcohol abuse is the lack of an appropriate rodent model. This study was designed to determine whether using a combination of a well-established model of chronic pain and alcohol preference/consumption in mice-surgical destabilization of the medial meniscus (DMM) 7, 9, 14, 16 and the 2-bottle ethanol choice, 2 respectively-is appropriate for studying chronic pain-induced ethanol intake. A positive outcome would allow further investigation of this approach as an appropriate avenue to investigate the basis of the comorbidity of pain and alcohol intake that results in alcohol abuse clinically.
Materials and methods

Animals
Ten C57BL/6J male mice (Jackson) were initially housed in groups of up to 4 in plastic-bottomed cages. Animals were housed in a temperature-and humidity-controlled room under a 12:12 hours light:dark cycle with lights on from 07:00 to 19:00 hour. Access to food and water was provided ad libitum. Mice were group housed with up to 3 littermates until 2 weeks before incapacitance testing at which time they were individually housed. All in vivo experiments were conducted with a protocol approved by the Institutional Animal Care and Use Committee at The University of North Carolina at Chapel Hill. Animal use was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.
Destabilization of the medial meniscus and incapacitance testing
The DMM model of osteoarthritis (OA), initially established by Glasson et al., 9 was performed as previously described. 14 Mice were 12 weeks of age at the time of DMM or sham surgery. Osteoarthritis was induced by transection of the meniscotibial ligament in the right knee. The sham-operated controls underwent the same surgery except that the meniscotibial ligament was not cut. Mice were allowed free activity in their home cages after surgery.
Four days before incapacitance testing, each mouse was habituated to the environment, handling and restraint necessary for performance of the test. On the test day, 13 weeks after surgery, mice were assessed for incapacitance of the operated right hind leg as previously described 3 ( Fig. 1A) . Weight bearing was measured by the downward pressure applied to plates of the Incapacitance Meter Tester (IITC Life Science, Woodland Hills, CA). The mean weight (g) of the left and right side was measured over a 5-second interval. Each measurement was repeated 10 times, and the average difference in the load-bearing side with the nonsurgical (contralateral) paw vs the surgical (ipsilateral) was calculated.
Two-bottle ethanol choice
Immediately after the determination of incapacitance of DMM mice vs sham controls, we exposed both groups of mice to the 2-bottle ethanol choice. 2 Mice had uninterrupted access to both water and ethanol throughout the 24-day trial. Initially, mice were exposed to a concentration of 2.5% ethanol for 4 days (days 1-4); the concentration of ethanol gradually increased to 5.0% (4 days; days 5-8), 10% (8 days; days 9-16), and 20% (8 days; days 17-24). Each day, the bottles were weighed and placement of the 2 bottles was switched to control for place preference. Every week, the body weights of the mice were measured. At the end of the trial, mice were rapidly decapitated and their hind limbs dissected for histological analysis.
Histological analysis
Hind limbs from the operated side were dissected and processed for histological analysis as previously described. 14 In brief, hematoxylin and eosin (HE) and Safranin-O/fast green midcoronal sections of each stifle joint were obtained and 1 representative HE-stained section from each joint was graded by an evaluator (V.U.) blinded to group assignment. The evaluation included the articular cartilage structure (ACS) score (0-12), synovial hyperplasia severity score in the medial compartment (0-3; 0 5 1 cell layer in synovium, 1 5 2-3 cell layers, 2 5 4-5 cell layers, and 3 5 5 or more cell layers), and osteophyte score for the medial tibial compartment (0-3). 13 An adjacent slide (;70 mm apart) was stained with Safranin-O/fast green and the Safranin-O (Saf-O) staining score (0-12) 15 for the medial tibial compartment was obtained.
Data analysis
GraphPad Prism (version 6.07) was used to statistically analyze all data. Incapacitance test data were analyzed using a Student unpaired t test for differences between sham and DMM subjects. Alcohol consumption (g EtOH consumed per kg body weight) and preference (mL EtOH consumed per total mL liquid consumed) with the 2-bottle choice were analyzed using 2-way repeatedmeasures analysis of variance (ANOVA). Repeated-measures ANOVA were performed independently for the different concentrations of ethanol (2.5%, 5.0%, 10%, and 20%). Alcohol consumption and preference data from day 24 at 20% EtOH concentration was not included in the final data set because of interruption of the night-time drinking cycle because of blood collection and breathe analysis (data not shown). Bonferroni multiple comparisons test was used when appropriate. A P , 0.05 was considered significant. Correlation between the incapacitance vs OA histological analyses and grams of EtOH consumed/ body weight vs OA histological analyses were determined using Pearson correlation coefficient. The grams of EtOH consumed in these analyses were the summed total over the entire 20% EtOH exposure. A P , 0.05 was considered significant.
Results
As a voluntary consummatory study, it was important to ensure that the body weight of the mice did not confound the volumetric intake of EtOH. Therefore, each week of the 2-bottle choice test the body weight of each mouse was recorded (grams) and compared between the sham and DMM groups. We found no statistical differences between the 2 groups at any of the time points (Fig. 1B) . The incapacitance of the mice correlated with certain measurements of the degree of OA severity in DMM and sham control mice, as measured with Safranin-O and HE staining (Fig. 1C) . Pearson product-moment correlation demonstrated no significant correlation between the change in weight (g) between the contralateral and ipsilateral paw and the scores for ACS (r 5 0.6255, P 5 0.0531) (Fig. 1D) , but did reach statistical significance with Safranin-O staining (r 5 0.8522, P 5 0.0017) (Fig. 1E) , osteophyte score (r 5 0.8595, P 5 0.0014) (Fig. 1F) , and the score for synovial hyperplasia (r 5 0.7773, P 5 0.0081) (Fig. 1G) .
Immediately after confirmation of incapacitance, mice were subjected to a 2-bottle ethanol choice of gradually increasing concentrations of EtOH (2.5, 5.0, 10%, and 20%) (Fig. 2) . Two-way repeated-measures ANOVA was performed on each concentration of EtOH. A significant interaction between DMM treatment and time was measured at 10 (F 7,56 5 3.812, P 5 0.0019) and 20% EtOH (F 6,48 5 4.827, P 5 0.0006) for alcohol consumption (Fig. 2A) . A significant effect of DMM was measured at the 20% EtOH concentration (F 1,8 5 15.95, P 5 0.0050) and alcohol preference (F 1,8 5 14.66, P 5 0.0006) (Fig. 2B) . A significant increase in consumption of EtOH by DMM mice vs sham controls was confirmed on days 16 (P , 0.001), 18 (P , 0.0001), 20 (P , 0.01), 21 (P , 0.01), and 22 (P , 0.01) and preference for EtOH on days 18 (P , 0.0001), 20 (P , 0.05), and 22 (P , 0.05) with Bonferroni multiple comparisons test. Importantly, no differences were measured in body weight or water consumption between the sham and DMM groups at any time point (data not shown).
Severity of osteoarthritis correlates with degree of alcohol consumption
Certain measurements of the OA severity in DMM and sham control mice, as measured with Safranin-O and HE staining, correlated with the amount of alcohol consumed. Pearson product-moment correlation confirmed a significant correlation between the grams of 20% EtOH consumed per kg body weight and the scores for ACS (r 5 0.9608, P , 0.0001) (Fig. 3A) , Safranin-O staining (r 5 0.8208, P 5 0.0036) (Fig. 3B) , and osteophyte score (r 5 0.8608, P 5 0.0048) (Fig. 3C) . The score for synovial hyperplasia did not correlate significantly with ethanol consumption (r 5 0.1742, P 5 0.6304) (Fig. 3D) . No significant correlation was found between incapacitance of the mice and the amount of ethanol consumed (r 5 0.5144, P 5 0.1282) (Fig. 3E ).
Discussion
In this study, we show that the DMM mouse model of OA induced a robust increase in EtOH intake and preference compared with sham controls. Mice which exhibit pronounced incapacitance of the surgically impaired hind limb proceeded to consume more ethanol per body weight at the highest concentration of EtOH (20%). Furthermore, significant correlations were demonstrated between EtOH intake and postmortem analyses of articular cartilage damage and osteophyte growth-histological measurements which both determine the severity of the OA. This finding suggests the possibility that the degree of ethanol intake in mice can be predicted by the severity of OA. A recent study by González-Sepúlveda et al. 10 in a mouse model of neuropathic pain demonstrated that partial sciatic nerve ligation also resulted in an increase in alcohol consumption and long-term anxiety and depressive-like behaviors. However, consumption of alcohol did not attenuate nociceptive behaviors in this protocol. In a separate study by Smith et al., 18 no increase in EtOH preference with the 2-bottle choice and a mouse model of chronic, inflammatory pain was observed. In this latter study, administration of Complete Freunds Adjuvant to the hind paw did not induce an increase in ethanol intake. Taken together, current data from this and other studies suggest that mouse models of DMM-induced OA and partial sciatic nerve ligation-induced neuropathic pain, but not chronic inflammatory pain, result in an increase in alcohol intake in mice. Thus, these mouse models could possibly allow suitable studying of the comorbidity of chronic pain and alcohol abuse.
In contrast to the study by González-Sepúlveda et al., 10 our present investigation did not assess whether EtOH ingestion reduced nociceptive behaviors. In a DMM study, antinociception would have been confirmed with reduced incapacitance of the DMM-impaired hind limb. However, because this was a voluntary consummatory experiment, measuring changes in incapacitance after EtOH consumption would not have been suitable. The amount of EtOH consumed would need to be controlled in order for such a measurement of incapacitance across subjects to be valid which is not feasible with voluntary consumption. Furthermore, although most EtOH consumption took place during the dark cycle, there were stark individual differences in the exact time of consumption. Therefore, the time of consumption would need to be controlled for to examine the analgesic effects of alcohol. Finally, the major finding of this study is that chronic osteoarthritic pain leads to enhanced EtOH consumption and this is not diminished by the lack of incapacitance measurements after EtOH consumption. However, this could make for a future direction whereby alcohol is involuntarily consumed by gavage or an intraintestinal catheter. Then, measurements on the effects of alcohol on incapacitance could be made in a controlled manner and at the same time to determine whether an increase in alcohol consumption underpins an increase in the severity of OA or vice versa. In the study by González-Sepúlveda et al., they showed no significant reduction in nociceptive behaviors with alcohol-a finding which is in contrast to both rodent 5 and human studies. 6, 19, 20 However, in addition to introducing several maladaptations including cancer, liver disease, etc., chronic alcohol intake has been demonstrated to exacerbate painful conditions over time. 1, 4 Therefore, a wide breadth of scientific literature concludes that alcohol should not be used as an analgesic.
One possible confounding aspects of our data is the low EtOH intake for the sham group of C57BL/6 mice. Studies with this strain of mice have shown consumption as high as 15 g EtOH per kg body weight. 21 However, a consideration must be made to the age of the mice at the time of exposure to the 2-bottle choice. In mice, adult naive mice consume less EtOH than adolescents. 12 At the time of the 2-bottle choice in our paradigm, mice are 25 weeks of age and last until 28 weeks of age. Therefore, we presume that the decrease in EtOH consumption in the sham controls compared with other studies is due to the age of the animals.
In summary, we demonstrate that after induction of OA using DMM surgery, a well-characterized model of OA in mice, there is a large increase in alcohol preference compared with sham surgery mice. In addition to having positive face validity to the human comorbid conditions of OA and chronic alcohol abuse, it also can serve as a model for chronic pain-induced alcohol consumption in general. With this model, investigations can be made with novel analgesics that aim to eliminate or reduce alcohol abuse in patients with chronic pain. Given the enormous burden to individuals and society, further studies which use this model to decipher the mechanisms of chronic pain-induced alcohol consumption are warranted.
